Skip to main content
RNAZ
NASDAQ Life Sciences

Transcode Therapeutics Adjourns Annual Meeting Due to Pending Nasdaq Review for Listing Compliance

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$8.61
Mkt Cap
$8.182M
52W Low
$3.82
52W High
$20.99
52W Position info
125% above low
Off High info
59% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

RNAZ has more than doubled off its 52-week low of $3.82.

Summary

Transcode Therapeutics adjourned its 2026 Annual Meeting of Stockholders until July 20, 2026, because Nasdaq has not yet completed its review of the company's listing application, which is required for a critical vote on preferred stock conversion.


Key Events · Corporate Governance and Compliance · RNAZ

  • Annual Meeting Adjourned

    The 2026 Annual Meeting of Stockholders was commenced on July 2, 2026, and immediately adjourned.

  • New Meeting Date Set

    The Annual Meeting is reconvened for July 20, 2026, at 9:30 a.m. Eastern Time.

  • Reason for Adjournment: Nasdaq Review Pending

    The adjournment is to allow Nasdaq to complete its review and approval of the company's initial listing application, which is required before the vote on Proposal 1 (conversion of Series A and Series B Non-Voting Convertible Preferred Stock into common stock).

  • Impact on Nasdaq Compliance

    This delay directly impacts the company's efforts to regain compliance with Nasdaq listing rules, following a previous deficiency notice, and prolongs uncertainty regarding its listing status.


Analysis · RNAZ · Life Sciences

Transcode Therapeutics adjourned its annual meeting, delaying a critical vote on converting preferred stock into common stock. This conversion is a key component of the company's plan to regain compliance with Nasdaq listing rules, following a previous deficiency notice. The delay, caused by Nasdaq's incomplete review of the company's listing application, prolongs uncertainty regarding the company's ability to resolve its delisting threat and continue operations, especially given its existing 'going concern' warning and short cash runway.

At the time of this filing, RNAZ was trading at $8.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.2M. The 52-week trading range was $3.82 to $20.99. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RNAZ - Latest Insights

RNAZ
Jul 02, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.61
Real-time Price: $8.55 info
Change: -$0.060 (-0.70%) info
Market Cap: $8.182M info
RNAZ
Jun 18, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.35
Real-time Price: $8.55 info
Change: +$3.20 (+60%) info
Market Cap: $8.182M info
RNAZ
Jun 03, 2026, 8:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $4.18
Real-time Price: $8.55 info
Change: +$4.37 (+105%) info
Market Cap: $8.182M info
RNAZ
Jun 03, 2026, 8:08 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.00
Real-time Price: $8.55 info
Change: +$4.55 (+114%) info
Market Cap: $8.182M info
RNAZ
Jun 02, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $5.29
Real-time Price: $8.55 info
Change: +$3.27 (+62%) info
Market Cap: $8.182M info
RNAZ
May 26, 2026, 6:46 AM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $5.70
Real-time Price: $8.55 info
Change: +$2.85 (+50%) info
Market Cap: $8.182M info
RNAZ
May 26, 2026, 6:43 AM EDT
Filing Type: 8-K/A
Importance Score:
9
Price at Filing: $5.70
Real-time Price: $8.55 info
Change: +$2.85 (+50%) info
Market Cap: $8.182M info
RNAZ
May 22, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.24
Real-time Price: $8.55 info
Change: +$2.31 (+37%) info
Market Cap: $8.182M info
RNAZ
May 15, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $6.60
Real-time Price: $8.55 info
Change: +$1.95 (+30%) info
Market Cap: $8.182M info
RNAZ
May 15, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $6.60
Real-time Price: $8.55 info
Change: +$1.95 (+30%) info
Market Cap: $8.182M info